arXiv subjects

David Cheng

Publications and source records attributed to David Cheng.

5 recordsLinked to original sources

arXiv2024

Another look at statistical inference with machine learning-imputed data

From structural biology to epidemiology, predictions from machine learning (ML) models increasingly complement costly gold-standard data, enabling faster, more affordable, and scalable scientific inquiry. In response, prediction-based (PB) inference has emerged to support statistical analysis that combines a large volume of predicted data with a small amount of gold-standard data. The goals of PB inference are twofold: (i) to mitigate bias arising from prediction error and (ii) to improve efficiency relative to classical inference based solely on gold-standard data. While early PB inference methods primarily focused on bias mitigation, improving efficiency remains an active area of research. Motivated by connections between PB inference and longstanding problems in statistics and related fields, we draw on the two-phase sampling literature to introduce an approach for Z-estimation with ML-imputed outcomes that is guaranteed to match or exceed the efficiency of classical inference, regardless of prediction quality. We demonstrate the utility of our approach through theoretical and numerical analyses as well as an application to UK Biobank data. We further establish new connections between existing PB inference approaches and foundational and contemporary statistical methods.

stat.ML↗

arXiv2021

Adaptive Combination of Randomized and Observational Data

Data from both a randomized trial and an observational study are sometimes simultaneously available for evaluating the effect of an intervention. The randomized data typically allows for reliable estimation of average treatment effects but may be limited in sample size and patient heterogeneity for estimating conditional average treatment effects for a broad range of patients. Estimates from the observational study can potentially compensate for these limitations, but there may be concerns about whether confounding and treatment effect heterogeneity have been adequately addressed. We propose an approach for combining conditional treatment effect estimators from each source such that it aggressively weights toward the randomized estimator when bias in the observational estimator is detected. This allows the combination to be consistent for a conditional causal effect, regardless of whether assumptions required for consistent estimation in the observational study are satisfied. When the bias is negligible, the estimators from each source are combined for optimal efficiency. We show the problem can be formulated as a penalized least squares problem and consider its asymptotic properties. Simulations demonstrate the robustness and efficiency of the method in finite samples, in scenarios with bias or no bias in the observational estimator. We illustrate the method by estimating the effects of hormone replacement therapy on the risk of developing coronary heart disease in data from the Women's Health Initiative.

stat.ME↗

arXiv2019

The Statistical Performance of Matching-Adjusted Indirect Comparisons

Indirect comparisons of treatment-specific outcomes across separate studies often inform decision-making in the absence of head-to-head randomized comparisons. Differences in baseline characteristics between study populations may introduce confounding bias in such comparisons. Matching-adjusted indirect comparison (MAIC) (Signorovitch et al., 2010) has been used to adjust for differences in observed baseline covariates when the individual patient-level data (IPD) are available for only one study and aggregate data (AGD) are available for the other study. The approach weights outcomes from the IPD using estimates of trial selection odds that balance baseline covariates between the IPD and AGD. With the increasing use of MAIC, there is a need for formal assessments of its statistical properties. In this paper we formulate identification assumptions for causal estimands that justify MAIC estimators. We then examine large sample properties and evaluate strategies for estimating standard errors without the full IPD from both studies. The finite-sample bias of MAIC and the performance of confidence intervals based on different standard error estimators are evaluated through simulations. The method is illustrated through an example comparing placebo arm and natural history outcomes in Duchenne muscular dystrophy.

stat.AP↗

arXiv2018

Robust and Efficient Semi-Supervised Estimation of Average Treatment Effects with Application to Electronic Health Records Data

We consider the problem of estimating the average treatment effect (ATE) in a semi-supervised learning setting, where a very small proportion of the entire set of observations are labeled with the true outcome but features predictive of the outcome are available among all observations. This problem arises, for example, when estimating treatment effects in electronic health records (EHR) data because gold-standard outcomes are often not directly observable from the records but are observed for a limited number of patients through small-scale manual chart review. We develop an imputation-based approach for estimating the ATE that is robust to misspecification of the imputation model. This effectively allows information from the predictive features to be safely leveraged to improve efficiency in estimating the ATE. The estimator is additionally doubly-robust in that it is consistent under correct specification of either an initial propensity score model or a baseline outcome model. It is also locally semiparametric efficient under an ideal semi-supervised model where the distribution of the unlabeled data is known. Simulations exhibit the efficiency and robustness of the proposed method compared to existing approaches in finite samples.We illustrate the method by comparing rates of treatment response to two biologic agents for treatment inflammatory bowel disease using EHR data from Partner's Healthcare.

stat.ME↗

arXiv2017

Estimating Average Treatment Effects with a Double-Index Propensity Score

We consider estimating average treatment effects (ATE) of a binary treatment in observational data when data-driven variable selection is needed to select relevant covariates from a moderately large number of available covariates $\mathbf{X}$. To leverage covariates among $\mathbf{X}$ predictive of the outcome for efficiency gain while using regularization to fit a parametric propensity score (PS) model, we consider a dimension reduction of $\mathbf{X}$ based on fitting both working PS and outcome models using adaptive LASSO. A novel PS estimator, the Double-index Propensity Score (DiPS), is proposed, in which the treatment status is smoothed over the linear predictors for $\mathbf{X}$ from both the initial working models. The ATE is estimated by using the DiPS in a normalized inverse probability weighting (IPW) estimator, which is found to maintain double-robustness and also local semiparametric efficiency with a fixed number of covariates $p$. Under misspecification of working models, the smoothing step leads to gains in efficiency and robustness over traditional doubly-robust estimators. These results are extended to the case where $p$ diverges with sample size and working models are sparse. Simulations show the benefits of the approach in finite samples. We illustrate the method by estimating the ATE of statins on colorectal cancer risk in an electronic medical record (EMR) study and the effect of smoking on C-reactive protein (CRP) in the Framingham Offspring Study.

stat.ME↗